Literature DB >> 11063157

Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection.

K Sasaki1, A Tsutsumi, N Wakamiya, K Ohtani, Y Suzuki, Y Watanabe, N Nakayama, T Koike.   

Abstract

BACKGROUND: Persistent infection with hepatitis C virus (HCV) leads to liver cirrhosis (LC) and often to liver cancer. Little is known about host factors that determine the variable natural history. Mannose-binding lectin (MBL) is an important constituent of the innate immune system. In white patients there is an association between codon 52 mutation of the MBL gene and persistent hepatitis B virus (HBV) infection. To determine whether MBL gene polymorphisms affect the course of HCV infection, we investigated the association between MBL gene polymorphisms and HCV infection in Japanese subjects.
METHODS: Fifty-two HCV-infected Japanese patients (8 with chronic inactive hepatitis (CIH), 31 with chronic active hepatitis (CAH), 13 with LC) and 50 normal controls were studied. MBL gene mutations were determined by means of polymerase chain reaction and restriction fragment length polymorphism analyses.
RESULTS: Codon 52 and codon 57 mutations were absent in all subjects. Homozygous mutation in codon 54 was present in one (0.9%) patient. Heterozygous codon 54 mutation was present in 17 (32%) of the 52 patients and in 21 (41%) of the controls. No significant difference in the frequency of codon 54 mutation was observed between patient and control groups. However, although no significant relationship was observed between MBL polymorphisms and the levels of HCV RNA, all patients with heterozygous or homozygous codon 54 mutations had CAH or LC. In contrast, 8 of the 34 patients without codon 54 mutation remained at CIH. (P = 0.0405).
CONCLUSION: MBL may be one of the factors that influence the course of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063157     DOI: 10.1080/003655200750023039

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  20 in total

1.  Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.

Authors:  Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex.

Authors:  K S Brown; M J Keogh; N Tagiuri; M J Grainge; J S Presanis; S D Ryder; W L Irving; J K Ball; R B Sim; T P Hickling
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

3.  Current status of novel antifibrotic therapies in patients with chronic liver disease.

Authors:  Michal Cohen-Naftaly; Scott L Friedman
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

4.  Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection.

Authors:  Paola Parrella; Davide Seripa; Maria G Matera; Monica Rinaldi; Emanuela Signori; Carolina Gravina; Antonietta P Gallo; Maria Prencipe; Elvira Grandone; Luciano Mariani; Paola Cordiali; Aldo Di Carlo; Patrizia Stentella; Antonio Pachì; Vito M Fazio
Journal:  Eur J Epidemiol       Date:  2007-02-15       Impact factor: 8.082

Review 5.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 6.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus.

Authors:  R Takahashi; A Tsutsumi; K Ohtani; D Goto; I Matsumoto; S Ito; N Wakamiya; T Sumida
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

8.  Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients.

Authors:  Eirini Koutsounaki; George N Goulielmos; Mary Koulentaki; Christianna Choulaki; Elias Kouroumalis; Emmanouil Galanakis
Journal:  J Clin Immunol       Date:  2008-07-01       Impact factor: 8.317

9.  Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.

Authors:  M L Alves Pedroso; A B W Boldt; L Pereira-Ferrari; R Steffensen; E Strauss; J C Jensenius; S O Ioshii; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

10.  Mannan-binding lectin and hepatitis C infection.

Authors:  D C Kilpatrick; T E S Delahooke; C Koch; M L Turner; P C Hayes
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.